skip to main content

Type 1 diabetes technology — SCE Endocrinology MCQ

Instant feedback + full explanation. One question, done properly.

ModerateDiabetesType 1 diabetes technologySCE Endocrinology

A 29-year-old woman with type 1 diabetes uses multiple daily injections and finger-prick testing. HbA1c is 61 mmol/mol and she has disabling nocturnal hypoglycaemia despite education and dose adjustment. She is anxious about sleeping alone. What is the most appropriate management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Offer real-time continuous glucose monitoring with alerts

NICE NG17 supports continuous glucose monitoring in adults with type 1 diabetes, particularly where hypoglycaemia is problematic. Increasing basal insulin would worsen nocturnal hypoglycaemia. Mixed insulin and sulfonylureas do not address the physiology of type 1 diabetes.

Reference: NICE NG17; BNF